Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Neurochem Int ; 58(3): 385-90, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21185899

RESUMO

Recent research data have shown that systemic administration of pyruvate and oxaloacetate causes an increased brain-to-blood glutamate efflux. Since increased release of glutamate during epileptic seizures can lead to excitotoxicity and neuronal cell death, we tested the hypothesis that glutamate scavenging mediated by pyruvate and oxaloacetate systemic administration could have a neuroprotective effect in rats subjected to status epilepticus (SE). SE was induced by a single dose of pilocarpine (350mg/kgi.p.). Thirty minutes after SE onset, a single dose of pyruvate (250mg/kgi.p.), oxaloacetate (1.4mg/kgi.p.), or both substances was administrated. Acute neuronal loss in hippocampal regions CA1 and hilus was quantitatively determined five hours after SE onset, using the optical fractionator method for stereological cell counting. Apoptotic cascade in the hippocampus was also investigated seven days after SE using caspase-1 and -3 activity assays. SE-induced neuronal loss in CA1 was completely prevented in rats treated with pyruvate plus oxaloacetate. The SE-induced caspase-1 activation was significantly reduced when rats were treated with oxaloacetate or pyruvate plus oxaloacetate. The treatment with pyruvate and oxaloacetate caused a neuroprotective effect in rats subjected to pilocarpine-induced SE.


Assuntos
Degeneração Neural/tratamento farmacológico , Fármacos Neuroprotetores/farmacologia , Ácido Oxaloacético/farmacologia , Ácido Pirúvico/farmacologia , Estado Epiléptico/prevenção & controle , Animais , Modelos Animais de Doenças , Masculino , Degeneração Neural/etiologia , Ácido Oxaloacético/uso terapêutico , Ácido Pirúvico/metabolismo , Ratos , Ratos Wistar , Estado Epiléptico/induzido quimicamente , Estado Epiléptico/complicações
2.
Biotechnol Lett ; 25(14): 1175-8, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12967008

RESUMO

NADP+-Isocitrate dehydrogenase (ICDH) activity was detected in cell-free extracts of Saccharopolyspora erythraea CA340, an erythromycin producer. Apparent Km values for DL-isocitrate and NADP+ were 0.14 microM and 0.026 microM, respectively. ATP, ADP, GTP, citric acid, oxaloacetate, alpha-ketoglutarate, glyoxalate and glyoxalate plus oxaloacetate, each at 1 mM concentration, caused 50, 20 10, 50, 25, 60, 20 and 50% inhibition of ICDH activity, respectively. Phosphoenolpyruvate, fructose 1,6-diphosphate and pyruvate had no effect. ICDH specific activity profile was growth-associated and activity with dextrose or fructose as sole carbon source, was twice of that obtained with lactose.


Assuntos
Isocitrato Desidrogenase/metabolismo , Saccharopolyspora/enzimologia , Meios de Cultura , Dimerização , Eletroforese em Gel de Poliacrilamida , Eritromicina/biossíntese , Fermentação , Frutose/metabolismo , Frutose/farmacologia , Glucose/metabolismo , Glucose/farmacologia , Concentração de Íons de Hidrogênio , Isocitrato Desidrogenase/biossíntese , Isocitrato Desidrogenase/química , Isocitratos/metabolismo , Ácidos Cetoglutáricos/metabolismo , Cinética , Micélio/enzimologia , Micélio/isolamento & purificação , NADP/metabolismo , Ácido Oxaloacético/farmacologia , Ácido Pirúvico/metabolismo , Saccharopolyspora/crescimento & desenvolvimento , Saccharopolyspora/metabolismo , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA